Research Article

High-Dose Chemotherapy with Autologous Hematopoietic Stem-Cell Rescue for Pediatric Brain Tumor Patients: A Single Institution Experience from UCLA

Table 1

Patient characteristics.

Patient numberAge at diagnosis (years)/ GenderDiagnosis, gradeLocationPrimary/recurrentHighest stage

110.9/MaleMedulloblastoma, IVPosterior fossa and Cervical-spineRecurrentM3
215.9/MaleNGGCTPinealPrimaryM0
30.9/MaleMedulloblastoma, IVPosterior fossaPrimaryM0
417.3/MaleNGGCTPinealPrimaryM0
52.9/FemaleAnaplastic Oligodendroglioma, IIIFrontal, LeftPrimaryM0
65.3/MaleSupratentorial PNET, IVCerebral, LeftPrimaryM0
70.6/MaleMedulloblastoma, IVPosterior fossaPrimaryM2
81.2/FemaleNeurocytoma, IIFrontal, RightRecurrentM3
918.6/MaleNGGCTPinealRecurrentM3
104.4/FemaleSupratentorial PNET, IVFrontal, LeftPrimaryM0
111.8/MaleSupratentorial PNET, IVFrontal, RightPrimaryM0
122.2/MaleAnaplastic Ependymoma, IIIOccipitoparietal, LeftPrimaryM0
1310.2/FemalePineoblastoma, IVPinealRecurrentM2
140.4/MaleMedulloblastoma, IVPosterior fossaPrimaryM3
152.4/FemaleMedulloblastoma, IVBrainstemPrimaryM0
162.1 /FemaleMedulloblastoma, IVPosterior fossaPrimaryM0
172.1/MaleSupratentorial PNET, IVFrontal, RightPrimaryM2
181.7/MaleMedulloblastoma, IVPosterior fossaPrimaryM2

NGGCT: nongerminomatous germ cell tumor.
PNET: primitive neuroectodermal tumor.